| 临床病理特征 | 胰腺癌伴新发糖尿病组 (n = 88) | 胰腺癌伴长病程糖尿病组 (n = 37) | P值 |
| 年龄 | 63 (55, 68) | 66 (61, 72) | 0.002 |
| 性别 |
|
| 0.189 |
| 男性 | 54 (61.4%) | 18 (48.6%) |
|
| 女性 | 34 (38.6%) | 19 (51.4%) |
|
| BMI (kg/m2) | 23.8 ± 3.2 | 23.8 ± 3.3 | 0.910 |
| 吸烟 | 25 (28.4%) | 4 (10.8%) | 0.033 |
| 饮酒 | 19 (21.6%) | 4 (10.8%) | 0.156 |
| 肿瘤位置 |
|
| 0.574 |
| 胰头 | 57 (64.8%) | 22 (59.5%) |
|
| 胰体尾 | 31 (35.2%) | 15 (40.5%) |
|
| 肿瘤大小 |
|
| 0.230 |
| ≤2 cm | 10 (11.4%) | 1 (2.7%) |
|
| >2 cm且≤4 cm | 59 (67.0%) | 25 (67.6%) |
|
| >4 cm | 19 (21.6%) | 11 (29.7%) |
|
| 分化程度 |
|
| 0.615 |
| 低分化 | 17 (23.0%) | 6 (20.0%) |
|
| 中低分化 | 12 (16.2%) | 7 (23.3%) |
|
| 中分化 | 43 (58.1%) | 15 (50.0%) |
|
| 高分化 | 2 (2.7%) | 2 (6.7%) |
|
| TNM分期 |
|
| 0.020 |
| I期 | 36 (40.9%) | 7 (18.9%) |
|
| II期 | 21 (23.9%) | 15 (40.5%) |
|
| III期 | 14 (15.9%) | 11 (29.7%) |
|
| IV期 | 17 (19.3%) | 4 (10.8%) |
|
| 淋巴结转移 | 37 (42.5%) | 20 (55.6%) | 0.187 |
| 肝转移 | 28 (32.2%) | 7 (18.9%) | 0.133 |
| 空腹血糖 | 8.7 (7.7, 11.3) | 9.6 (7.5, 11.2) | 0.850 |
| CEA | 4.2 (2.4, 7.1) | 3.5 (2.4, 9.6) | 0.800 |
| CA19-9 | 248.4 (72.5, 576.8) | 170.1 (56.5, 515.9) | 0.525 |